ici ltici seek gain specialty business imperial chemical industries plc large chemical company united kingdom expand specialty chemical drug business year 1986 result chairmanelect denys henderson we expect shift company high valueadde business continue broaden base henderson tell reporter informal meeting here ici today announce formation us drug company ici pharma which stuart pharmaceuticals unit double current pharmaceutical sale 11 billion dlrs 1990 henderson say our pharmaceutical business lose glaxos glaxo holdings plc not icis pharmaceutical division large drug maker glaxo uk year us drug sale 40 pct worldwide drug sale 15 billion dlrs turn bring 27 pct total profit estimate 1990 icis pharmaceutical division account 30 pct total company profit the drug division bring high rate return aw clements finance director ici meeting henderson us drug concern basically act sale force double exposure drug doctor ici hire 145 salesperson october one henderson major product company pipeline expect bring sale 200 mln dlrs annually statil treatment diabetic complication zoladex treatment advanced prostate cancer carwin treatment mild moderate congestive heart failure henderson us food drug administration approval market statil zoladex joint licensing agreement merck ltmrk expect 1989 ici expect file permission market carwin us year henderson companys 1987 result top 1986 income 888 mln dlrs 545 dlrs adr sale 15 billion dlrs decline much henderson 1987 result boost glidden paint ici buy november 580 mln dlrs unit hanson industries inc henderson ici billion dlrs acquisition year company make 40 acquisition large glidden acquisition make year rule acquisition pharmaceutical concern too expensive henderson role chairman effective april take sir john harveyjones retire big challenge ahead lie continue earning momentum ici establish past year restructure sell unprofitable business